SCHEMBL264035

SCHEMBL264035

Cn1c(=O)[nH]n(-c2ccccc2)c1=O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3A P49840 3/20 0.45
GSK3B P49841 3/20 0.45
TSHR P16473 1/20 0.44
MPI P34949 1/20 0.44
GAA P10253 3/20 0.43
LMNA P02545 2/20 0.43
ALDH1A1 P00352 2/20 0.43
POLB P06746 2/20 0.43
MAPT P10636 2/20 0.43
ALOX15 P16050 1/20 0.43
BLM P54132 1/20 0.43
ATM Q13315 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
PGR P06401 1/20 0.43
HTT P42858 1/20 0.42
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
DDB1 Q16531 1/20 0.41
CRBN Q96SW2 1/20 0.41
MAPK1 P28482 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL264757 0.78 GSK3A (0.54) GSK3AGSK3BTSHRMPIGAA
SCHEMBL267709 0.77 ALDH1A1 (0.49) GSK3AGSK3BTSHRMPIGAA
SCHEMBL23895082 0.74 GSK3A (0.50) GSK3AGSK3BTSHRMPIGAA
SCHEMBL8472583 0.71 NTRK1 (0.57) GSK3AGSK3BTSHRGAALMNA
SCHEMBL24327924 0.71 PGR (0.49) GSK3AGSK3BALDH1A1PGRHTT
SCHEMBL2041567 0.69 GAA (0.44) GSK3AGSK3BTSHRMPIGAA
SCHEMBL11613205 0.69 MEN1 (0.47) GSK3AGSK3BTSHRMPIGAA
SCHEMBL13562508 0.68 DAO (0.53) GSK3AGSK3BALDH1A1MEN1KMT2A
SCHEMBL5326615 0.68 GSK3A (0.55) GSK3AGSK3BTSHRMPIGAA
SCHEMBL8127154 0.67 GSK3A (0.54) GSK3AGSK3BTSHRLMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1655070-B1 OXIDATION CATALYST ASAHI KASEI CHEMICALS CORP (JP) 2015-07-15 EP disclosed
US-8133834-B2 Oxidation catalyst ASAHI KASEI CHEMICALS CORPORATION (JP) 2012-03-13 US disclosed
US-20100069670-A1 Oxidation catalyst ASAHI KASEI CHEMICALS CORPORATION (JP) 2010-03-18 US disclosed
US-20060229471-A1 Oxidation catalyst ASAHI KASEI CHEMICALS CORPORATION (JP) 2006-10-12 US disclosed
EP-1655070-A1 OXIDATION CATALYST Asahi Kasei Chemicals Corporation (JP) 2006-05-10 EP disclosed
US-4087534-A N-haloalkylmio urazole pesticides OVADIA DAVID 1978-05-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100069670-A1 Oxidation catalyst PPOX, SOD1, HAO2 GSK3A 4315/4885GSK3B 4503/4885TSHR 4696/4885
US-20060229471-A1 Oxidation catalyst PPOX, SOD1, HAO2 GSK3A 4315/4885GSK3B 4503/4885TSHR 4696/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.